Human umbilical cord mesenchymal stem cell–derived exosomes ameliorate ovarian aging by inhibiting ferroptosis
Reproduction · 2026
DOI: 10.1093/reprod/xaag104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2026. Verfasst von Chia-Jung Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Exosomes, Ferroptosis, Mesenchymal Stem Cells, Ovary. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
In brief: Ovarian aging and the resulting decline in oocyte quality remain significant challenges for female reproductive health and fertility. This study demonstrates that human umbilical cord mesenchymal stem cell–derived exosomes can partially improve ovarian aging-associated phenotypes by activating NRF2-mediated antioxidant defenses and inhibiting ferroptosis, offering a promising cell-free therapeutic strategy. Abstract: Ovarian aging is characterized by a decline in oocyte quantity and quality, often driven by oxidative stress and cellular damage. Human umbilical cord mesenchymal stem cell–derived exosomes (hUC-MSC-Exos) have emerged as a potent cell-free therapy for regenerative medicine. In this study, female mice with early ovarian aging (31–33 weeks; n = 8 per group) received 10 intraperitoneal injections of hUC-MSC-Exos (240 µL/dose, 6.5 × 10¹⁰ particles/mL) over 2 weeks. Ovarian function, follicular development, DNA damage, and ferroptosis-related markers were evaluated. hUC-MSC-Exo treatment significantly increased the number of primary and antral follicles without a significant change in primordial follicle counts. Exosome administration reduced genomic stress, evidenced by decreased terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) intensity, and improved oocyte yield and mitochondrial metabolic state. Mechanistically, hUC-MSC-Exos promoted the nuclear translocation of Nuclear factor erythroid 2 related factor 2 (NRF2), a master antioxidant regulator. This activation was accompanied by the suppression of ferroptosis, indicated by upregulation of GPX4 and SLC7A11 and downregulation of 4-HNE and ACSL4. Furthermore, exosome treatment restored ovarian functional markers (anti-Müllerian hormone [AMH], BMP15) and steroidogenic proteins (CYP11A1, 3β-HSD, StAR). These findings suggest that hUC-MSC-Exos mitigate age-related ovarian dysfunction by modulating NRF2-mediated antioxidant defenses and inhibiting ferroptosis, offering a promising candidate that warrants validation with functional reproductive endpoints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Institute of Biopharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Center of General Education, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
- School of Computing, National University of Singapore, Singapore, Singapore.
- National Museum of Marine Biology & Aquarium, Pingtung, Taiwan.
- Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan.
ORCID-Profile: Chia-Jung Li, Zhi-Hong Wen
Förderung
- National Science and Technology Council
Zitieren
APA
Li, C. J., Lin, L. T., Lin, P. H., Wang, B., Wen, Z. H., & Tsui, K. H. (2026). Human umbilical cord mesenchymal stem cell–derived exosomes ameliorate ovarian aging by inhibiting ferroptosis. Reproduction. https://doi.org/10.1093/reprod/xaag104
Vancouver
Li CJ, Lin LT, Lin PH, Wang B, Wen ZH, Tsui KH. Human umbilical cord mesenchymal stem cell–derived exosomes ameliorate ovarian aging by inhibiting ferroptosis. Reproduction. 2026. doi:10.1093/reprod/xaag104
BibTeX
@article{Li2026,
author = {Li, Chia-Jung and Lin, Li-Te and Lin, Pei-Hsuan and Wang, Boyang and Wen, Zhi-Hong and Tsui, Kuan-Hao},
title = {Human umbilical cord mesenchymal stem cell–derived exosomes ameliorate ovarian aging by inhibiting ferroptosis},
journal = {Reproduction},
year = {2026},
doi = {10.1093/reprod/xaag104}
}
EUVIMED